Sector
PharmaceuticalsOpen
₹3.75Prev. Close
₹3.8Turnover(Lac.)
₹0.37Day's High
₹3.75Day's Low
₹3.6552 Week's High
₹052 Week's Low
₹0Book Value
₹-9.83Face Value
₹10Mkt Cap (₹ Cr.)
7.06P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 |
|---|---|---|---|---|
Equity Capital | 276.67 | 19.34 | 19.34 | 28.64 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -38.36 | 269.13 | 337.94 | 243.01 |
Net Worth | 238.31 | 288.47 | 357.28 | 271.65 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
|---|---|---|
Revenue | 151.48 | 824.84 |
yoy growth (%) | -81.63 | |
Raw materials | -113.18 | -616.41 |
As % of sales | 74.71 | 74.73 |
Employee costs | -18.8 | -20.44 |
| Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
|---|---|---|
Profit before tax | -152.1 | -46.76 |
Depreciation | -66.03 | -60.79 |
Tax paid | -19.02 | -22.04 |
Working capital | -269.65 | |
Other operating items |
| Y/e 31 Mar | Mar-2012 | Mar-2011 |
|---|---|---|
Growth matrix (%) | ||
Revenue growth | -81.63 | |
Op profit growth | -120.84 | |
EBIT growth | -226.63 | |
Net profit growth | 346.88 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Purnandu Jain
Whole Time Executive Director
Girraj Vijayvargiya
Director
Dileep Shinde
Director
Clifton Zimmermann
Company Secretary
S C Rane
Director
Ramesh Batham
C-306 Crystal Plaza,
Andheri Link Road Andheri(W),
Maharashtra - 400053
Tel: 91-22-40682300
Website: http://www.ankurdrugs.com
Email: [email protected]
106 Mhada Shp Cmplx,
New Link Road, Jogeshwari (W),
Mumbai - 400102
Tel: 91-22-26303348/26303
Website: www.ajel.in
Email: [email protected]
Summary
Ankur Drugs and Pharma Ltd is engaged in contract manufacturing of pharmaceuticals formulations. The company has three manufacturing units: two in Himachal Pradesh and one in Daman. Its business segme...
Read More
Reports by Ankur Drugs & Pharma Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.